NasdaqGM - Delayed Quote USD

Rani Therapeutics Holdings, Inc. (RANI)

0.5599
+0.0054
+(0.97%)
At close: June 4 at 4:00:01 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,200
1,028
0
0
2,717
Operating Expense
48,779
50,628
66,099
63,451
54,316
Operating Income
-47,579
-49,600
-66,099
-63,451
-51,599
Net Non Operating Interest Income Expense
-3,250
-3,270
-1,784
177
-377
Other Income Expense
--
-3,714
--
--
-1,071
Pretax Income
-54,543
-56,584
-67,883
-63,274
-53,047
Tax Provision
--
--
0
70
41
Net Income Common Stockholders
-29,799
-30,018
-33,970
-30,588
-8,331
Diluted NI Available to Com Stockholders
-29,799
-30,018
-33,970
-30,588
-8,331
Basic EPS
-0.98
--
-1.33
-1.28
-0.43
Diluted EPS
-0.98
--
-1.33
-1.28
-0.43
Basic Average Shares
30,327.5000
--
25,505
23,817
19,534
Diluted Average Shares
30,327.5000
--
25,505
23,817
19,534
Total Operating Income as Reported
-51,293
-53,314
-66,099
-63,451
-51,599
Total Expenses
48,779
50,628
66,099
63,451
54,316
Net Income from Continuing & Discontinued Operation
-29,799
-30,018
-33,970
-30,588
-8,331
Normalized Income
-26,085
-26,304
-33,970
-30,588
-7,549.1700
Interest Income
1,432
1,763
3,301
1,248
89
Interest Expense
4,682
5,033
5,085
1,071
466
Net Interest Income
-3,250
-3,270
-1,784
177
-377
EBIT
-49,861
-51,551
-62,798
-62,203
-52,581
EBITDA
-48,830
-50,523
-61,976
-61,655
-52,084
Reconciled Depreciation
1,031
1,028
822
548
497
Net Income from Continuing Operation Net Minority Interest
-29,799
-30,018
-33,970
-30,588
-8,331
Total Unusual Items Excluding Goodwill
-3,714
-3,714
0
0
-1,071
Total Unusual Items
-3,714
-3,714
0
0
-1,071
Normalized EBITDA
-45,116
-46,809
-61,976
-61,655
-51,013
Tax Rate for Calcs
0
0
0
0
0.0003
Tax Effect of Unusual Items
0
0
0
0
-289.1700
12/31/2021 - 7/30/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

FBLG FibroBiologics, Inc.
0.8498
+7.77%
 
CNTX Context Therapeutics Inc.
0.5753
-1.15%
 
TNYA Tenaya Therapeutics, Inc.
0.5267
+7.49%
 
INTS Intensity Therapeutics, Inc.
0.4720
-10.10%
 
IMUX Immunic, Inc.
0.7750
+6.11%
 
JSPR Jasper Therapeutics, Inc.
6.00
+1.69%
 
HOWL Werewolf Therapeutics, Inc.
1.3100
-3.68%
 
KAPA Kairos Pharma, Ltd.
0.5206
+15.69%
 
SKYE Skye Bioscience, Inc.
2.2400
-2.18%
 
OVID Ovid Therapeutics Inc.
0.3096
+3.65%